Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

327 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tissue MicroRNA Expression as a Predictor of Response to Immunotherapy in NSCLC Patients.
Grenda A, Krawczyk P, Błach J, Chmielewska I, Kubiatowski T, Kieszko S, Wojas-Krawczyk K, Kucharczyk T, Jarosz B, Paśnik I, Borowiec-Bar M, Frąk M, Kieszko R, Szczyrek M, Reszka K, Krukowska K, Kolak A, Mańdziuk S, Kowalski D, Sawicki M, Świniuch D, Starosławska E, Ramlau R, Szumiło J, Krzakowski M, Milanowski J. Grenda A, et al. Among authors: kowalski d. Front Oncol. 2021 Feb 8;10:563613. doi: 10.3389/fonc.2020.563613. eCollection 2020. Front Oncol. 2021. PMID: 33628725 Free PMC article.
Concurrent chemotherapy and short course radiotherapy in patients with stage IIIA to IIIB non-small cell lung cancer not eligible for radical treatment: results of a randomized phase II study.
Nawrocki S, Krzakowski M, Wasilewska-Tesluk E, Kowalski D, Rucinska M, Dziadziuszko R, Sowa A. Nawrocki S, et al. Among authors: kowalski d. J Thorac Oncol. 2010 Aug;5(8):1255-62. doi: 10.1097/JTO.0b013e3181e15d33. J Thorac Oncol. 2010. PMID: 20592630 Free article. Clinical Trial.
Evaluation of antitumor activity using change in tumor size of the survivin antisense oligonucleotide LY2181308 in combination with docetaxel for second-line treatment of patients with non-small-cell lung cancer: a randomized open-label phase II study.
Natale R, Blackhall F, Kowalski D, Ramlau R, Bepler G, Grossi F, Lerchenmüller C, Pinder-Schenck M, Mezger J, Danson S, Gadgeel SM, Summers Y, Callies S, André V, Das M, Lahn M, Talbot D. Natale R, et al. Among authors: kowalski d. J Thorac Oncol. 2014 Nov;9(11):1704-8. doi: 10.1097/JTO.0000000000000285. J Thorac Oncol. 2014. PMID: 25436803 Free PMC article. Clinical Trial.
Preventing central nervous system metastases in non-small cell lung cancer.
Krawczyk P, Duchnowska R, Nicoś M, Kowalski D, Wojas-Krawczyk K. Krawczyk P, et al. Among authors: kowalski d. Expert Rev Anticancer Ther. 2018 Nov;18(11):1077-1083. doi: 10.1080/14737140.2018.1521273. Epub 2018 Sep 21. Expert Rev Anticancer Ther. 2018. PMID: 30198357 Review.
Solitary fibrous tumour along with non-small-cell lung cancer and Doege-Potter syndrome.
Piórek A, Kowalski D, Płużański A, Szołkowska M, Wągrodzki M, Koseła-Paterczyk H, Krzakowski M. Piórek A, et al. Among authors: kowalski d. Kardiochir Torakochirurgia Pol. 2019 Mar;16(1):49-51. doi: 10.5114/kitp.2019.83948. Epub 2019 Apr 4. Kardiochir Torakochirurgia Pol. 2019. PMID: 31043978 Free PMC article. No abstract available.
Health-Related Quality of Life With Carboplatin-Paclitaxel or nab-Paclitaxel With or Without Pembrolizumab in Patients With Metastatic Squamous Non-Small-Cell Lung Cancer.
Mazieres J, Kowalski D, Luft A, Vicente D, Tafreshi A, Gümüş M, Laktionov K, Hermes B, Cicin I, Rodríguez-Cid J, Wilson J, Kato T, Ramlau R, Novello S, Reddy S, Kopp HG, Piperdi B, Li X, Burke T, Paz-Ares L. Mazieres J, et al. Among authors: kowalski d. J Clin Oncol. 2020 Jan 20;38(3):271-280. doi: 10.1200/JCO.19.01348. Epub 2019 Nov 21. J Clin Oncol. 2020. PMID: 31751163 Free article. Clinical Trial.
Randomized Phase III Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, With Docetaxel Versus Docetaxel in Advanced Non-Small-Cell Lung Cancer (GALAXY-2).
Pillai RN, Fennell DA, Kovcin V, Ciuleanu TE, Ramlau R, Kowalski D, Schenker M, Yalcin I, Teofilovici F, Vukovic VM, Ramalingam SS. Pillai RN, et al. Among authors: kowalski d. J Clin Oncol. 2020 Feb 20;38(6):613-622. doi: 10.1200/JCO.19.00816. Epub 2019 Dec 12. J Clin Oncol. 2020. PMID: 31829907 Clinical Trial.
ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer.
Planchard D, Reinmuth N, Orlov S, Fischer JR, Sugawara S, Mandziuk S, Marquez-Medina D, Novello S, Takeda Y, Soo R, Park K, McCleod M, Geater SL, Powell M, May R, Scheuring U, Stockman P, Kowalski D. Planchard D, et al. Among authors: kowalski d. Ann Oncol. 2020 May;31(5):609-618. doi: 10.1016/j.annonc.2020.02.006. Epub 2020 Feb 20. Ann Oncol. 2020. PMID: 32201234 Free article. Clinical Trial.
Lung Cancer in Poland.
Adamek M, Biernat W, Chorostowska-Wynimko J, Didkowska JA, Dziadziuszko K, Grodzki T, Jassem J, Kępka L, Kowalski D, Krawczyk P, Krzakowski M, Nikliński J, Langfort R, Olszewski W, Orłowski T, Ramlau R, Rzyman W, Wrona A, Zieliński M, Dziadziuszko R. Adamek M, et al. Among authors: kowalski d. J Thorac Oncol. 2020 Aug;15(8):1271-1276. doi: 10.1016/j.jtho.2020.03.035. J Thorac Oncol. 2020. PMID: 32718535 Free article. No abstract available.
327 results